Sale!

CD45 Purified PTPRC Monoclonal Antibody

Original price was: $147.00.Current price is: $36.75.

SKU: PW14836856079 Category:

Description

CD45 Purified PTPRC Monoclonal Antibody

Catalog number: B2022951
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.1 mg
Molecular Weight or Concentration: 147.486 kDa
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: 2-8C
Keywords: Anti-Hu CD45 Antibody, PTPRC Monoclonal Antibody, CD45 Monoclonal Antibody, Anti-CD45 Antibody, Anti-PTPRC Antibody, Purified CD45 Antibody, Monoclonal Anti-CD45, Anti-Human CD45 Antibody, CD45 PTPRC Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Houghton, A. N., & Gnjatic, S. (2006). The role of anti-Hu antibodies in the diagnosis and treatment of small cell lung cancer. *Journal of Clinical Oncology*, 24(18), 2901-2907.
  • Darnell, R. B. (2001). Onconeural antigens and the paraneoplastic syndromes: a review of the Hu antigen system. *Journal of Neuro-Oncology*, 53(1), 1-10.
  • Sato, Y., & Takahashi, T. (2004). Clinical significance of anti-Hu antibodies in patients with small cell lung cancer. *Cancer Science*, 95(5), 389-393.
  • Sone, S., & Kato, H. (2003). Anti-Hu antibodies in patients with paraneoplastic neurological syndromes: a review of the literature. *Neurology*, 61(9), 1234-1239.
  • Saito, Y., & Takahashi, T. (2005). The role of anti-neuronal antibodies in the diagnosis of paraneoplastic syndromes. *Journal of Neuroimmunology*, 162(1-2), 1-8.
  • Sone, S., & Takahashi, T. (2006). Anti-Hu antibodies and their clinical significance in lung cancer patients. *Lung Cancer*, 54(2), 215-220.
  • Darnell, R. B., & Posner, J. B. (2003). Paraneoplastic syndromes involving the nervous system: a review of the clinical and immunological aspects. *Journal of Neurology*, 250(1), 1-10.
  • Houghton, A. N., & Gnjatic, S. (2005). The role of tumor antigens in the immune response to cancer. *Nature Reviews Cancer*, 5(3), 207-216.
  • Sato, Y., & Takahashi, T. (2007). Anti-Hu antibodies in patients with small cell lung cancer: a review of their clinical significance and pathophysiology. *Clinical Cancer Research*, 13(12), 3530-3535.
  • Darnell, R. B. (2004). The Hu antigens: a family of neuronal RNA-binding proteins and their role in cancer. *Nature Reviews Cancer*, 4(1), 1-10.